Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant

NEW JERSEY (BLOOMBERG) - Johnson & Johnson said its Covid-19 vaccine study has been temporarily halted due to an unexplained illness in a trial participant, the second time that a front-runner developer has encountered this situation in the intensifying race for immunisation.

The Straits Times | I+D | Farmacia |

Leer noticia completa en el medio original
Spanish